Eloxx Pharmaceuticals, Inc. (ELOX) News
Track canonical SquawkNews coverage tagged to ELOX, Eloxx Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Eloxx Pharmaceuticals Reports Q2 2026 Results
Eloxx Pharmaceuticals reports second quarter 2026 financial results and provides business update
EARNINGS | Aug 12, 2026, 10:01 AM UTC
L
ELOX Initiated Outperform W/$40.00 PT at LifeSci Capital
ELOX Initiated Outperform W/$40.00 PT at LifeSci Capital
EQUITY | Jul 22, 2026, 12:02 PM UTC
L
ELOX Initiated Buy W/$43.00 PT at Guggenheim
ELOX Initiated Buy W/$43.00 PT at Guggenheim
EQUITY | Jul 20, 2026, 11:49 AM UTC
L
ELOX new Buy W/ $43 PT @ GUGG
ELOX new Buy W/ $43 PT @ GUGG
EQUITY | Jul 20, 2026, 11:36 AM UTC
L
Eloxx Pharmaceuticals initiated with bullish view at Guggenheim
Eloxx Pharmaceuticals initiated with bullish view at Guggenheim
EQUITY | Jul 20, 2026, 12:44 AM UTC
L
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Can Fite Biopharma (AMEX: CANF ) shares rose 43.8% to $4.27 during Wednesday's regular session. The company's market cap stands at $6.3 million. Regencell Bioscience (NASDAQ: RGC ) stock moved upwards by 35.79% t
EQUITY | Jul 01, 2026, 05:05 PM UTC